FLIBANSERIN: ENHANCED PHARMACOVIGILANCE STUDY TO ASSESS AND ANALYZE THE RISKS OF ADVERSE EVENTS OF SPECIAL INTEREST Millheiser, L., Faragasso, A., Donatucci, S., Brown, L. ELSEVIER SCI LTD. 2020: S31

View details for Web of Science ID 000565226600064